PExA is a Swedish company that has developed a non-invasive technology for sampling human small airways to facilitate biomarker identification and early diagnosis of lung diseases. This solution addresses the critical need for improved diagnostic methods in respiratory health, enabling timely intervention and better patient outcomes.
Funding
$54.3K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current methods for diagnosing and monitoring lung diseases often involve invasive procedures or lack the sensitivity to detect early changes in the small airways. This makes it difficult to identify biomarkers and diagnose diseases like COPD, asthma, and lung cancer in their early stages, hindering timely intervention and effective treatment.
Solution
PExA offers a non-invasive technology for sampling the Respiratory Tract Lining Fluid (RTLF) from the distal airways through exhaled air. The PExA system collects microscopic particles from the exhaled air, sorts them by size, and captures them on a substrate for analysis. This method allows for quantitative and reproducible measurements of changes in the composition of the lining fluid, providing access to potential biomarkers for various respiratory diseases. The PExA 2.0 instrument features user-friendly software that guides the sampling process, records breathing patterns, and counts particles in real time, enabling researchers to monitor total collected mass and exhaled air volume.
Target Audience
The primary target audience includes lung research centers within healthcare services, academia, and pharmaceutical companies actively seeking biomarkers for respiratory diseases.
Features
- Non-invasive collection of exhaled particles for biomarker discovery
- Patented instrument for capturing and sorting particles by size
- Collection of Respiratory Tract Lining Fluid (RTLF) from the distal airways
- PExA 2.0 instrument with simplified design and user-friendly software
- Real-time monitoring of breathing patterns and particle counts
- Data storage in a format that enables direct control of sampling and further analysis
- Compatibility with conventional analysis techniques such as ELISA, MS, LC, and HPLC